Merdury Biopharmaceutical Corporation (TPEX:6932)
7.98
-0.01 (-0.13%)
May 8, 2026, 1:52 PM CST
-38.38% (1Y)
| Market Cap | 3.37B -38.4% |
| Revenue (ttm) | n/a |
| Net Income | -67.23M |
| EPS | -0.16 |
| Shares Out | 422.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 168,028 |
| Average Volume | 621,663 |
| Open | 7.99 |
| Previous Close | 7.99 |
| Day's Range | 7.61 - 8.00 |
| 52-Week Range | 4.95 - 13.25 |
| Beta | -1.25 |
| RSI | 48.21 |
| Earnings Date | May 14, 2026 |